In this study, we found that SESN2 expression was significantly up‐regulated in both HCC cells and tissues at first, and the increased expression of SESN2 was markedly correlated with sorafenib sensitivity of HCC cells. This evidence concerns the gene SESN2 and hepatocellular carcinoma.